AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...

Webb took on several high-profile public roles in Hong Kong to champion the interest of shareholders and investors, including ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) ...

ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...

For patients undergoing prostate radiotherapy, acute toxicity is associated with late toxicity and decrement in qua ...

Gozetotide binds to the cancer cells with prostate-specific membrane antigen (PSMA) on their surface, making them visible ...

A prostate cancer support group is hosted by the Beth C. Wright Cancer Resource Center the fourth Wednesday of each month ...

Six non-Masonic charities are set to benefit from a £75,000 funding handout by the Freemasons of Ireland Jubilee Benevolent and Welfare Fund.

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including ...

The Scientific Review Committee (SRC) charter is to review the safety data from the patients treated in the Phase I portion ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...

Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient ...